Table 1. Baseline characteristics of the study population.
| AF patients (n = 105) | AF-free controls (n = 14) | P-value | |
|---|---|---|---|
| Age, years | 62± 9 | 58 ± 11 | 0.105 |
| Males (%) | 65 | 50 | 0.282 |
| Paroxysmal AF (%) | 51 | - | - |
| Lone AF (%) | 71 | - | - |
| AF history, months | 60 (2–540) | - | - |
| CHADS2-Score | 1 (0–4) | - | - |
| CHA2DS2-VASc-Score | 2 (0–7) | - | - |
| BMI, kg/m2 | 29 ± 5 | 26 ± 4 | 0.074 |
| LAD, mm | 42 ± 6 | 39 ± 7 | 0.115 |
| LVEF (%) | 60 ± 8 | 59 ± 11 | 0.787 |
| eGFR, ml/min | 97 ± 30 | 100 ± 31 | 0.759 |
Abbreviations: BMI—body mass index; LAD—left atrial diameter; LVEF—left ventricular ejection fraction; eGFR—estimated glomerular filtration rate
Data are presented as median (interquartile range) or mean value ± SD.